Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers

Cancer Research

Volumn 66, Issue 9, 2006, Pages 4617-4626

  Imoto, Issei ^a,b   Izumi, Hiroyuki ^a   Yokoi, Sana ^a,b   Hosoda, Hiroshi ^c   Shibata, Tatsuhiro ^d   Hosoda, Fumie ^b,d   Ohki, Misao ^d   Hirohashi, Setsuo ^d   Inazawa, Johji ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOKYO KYOSAI HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; CELL GROWTH; CHROMOSOME BAND; CHROMOSOME DELETION; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTOCADHERIN 20 GENE; TUMOR SUPPRESSOR GENE;

AGED; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENE TARGETING; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 33646422462     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-4437     Document Type: Article

References (41)

1. Yagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization and neurologic diversity. Genes Dev 2000;14:1169-80.
2. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci 2001;114:629-41.
3. Nollet F, Kools P, van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 2000;299:551-72.
4. Takeichi M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990;59:237-52.
5. Wu Q, Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 1999;97:779-90.
6. Sano K, Tanihara H, Heimark RL, et al. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J 1993;12:2249-56.
7. Bradley RS, Espeseth A, Kintner C. NF-protocadherin, a novel member of the cadherin superfamily, is required for Xenopus ectodermal differentiation. Curr Biol 1998;8:325-34.
8. Yamagata K, Andreasson KI, Sugiura H, et al. Arcadlin is a neural activity-regulated cadherin involved in long term potentiation. J Biol Chem 1999;274:19473-9.
9. Okazaki N, Takahashi N, Kojima S, Masuho Y, Koga H. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 2002;23:1139-48.
10. Stassar MJ, Devitt G, Brosius M, et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 2001;85:1372-82.
11. Chen MW, Vacherot F, De La Taille A, et al. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells. Oncogene 2002;21:7861-71.
12. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond) 1986;323:643-6.
13. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Wash DC) 1994;264:436-40.
14. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Wash DC) 1996;271:350-3.
15. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Wash DC) 1997;275:1943-7.
16. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004;95:559-63.
17. Sonoda I, Imoto I, Inoue J, et al. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma. Cancer Res 2004;64:3741-7.
18. Izumi H, Inoue J, Yokoi S, et al. Frequent Silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 2005;14:1-11.
19. Takada H, Imoto I, Tsuda H, et al. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene 2005;24:8051-60.
20. Noguchi M, Furuya S, Takeuchi T, Hirohashi S. Modified formalin and methanol fixation methods for molecular biological and morphological analyses. Pathol Int 1997;47:685-91.
21. Tanabe C, Aoyagi K, Sakiyama T, et al. Evaluation of a whole-genome amplification method based on adaptor-ligation PCR of randomly sheared genomic DNA. Genes Chromosomes Cancer 2003;38:168-76.
22. Toyota M, Ho C, Ahuja N, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999;59:2307-12.
23. Fukazawa H, Mizuno S, Uehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem 1995;228:83-90.
24. Imoto I, Yuki Y, Sonoda I, et al. Identification of ZASC1 encoding a Kruppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas. Cancer Res 2003;63:5691-6.
25. Takada H, Imoto I, Tsuda H, et al. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005;96:100-10.
26. Shiseki M, Kohno T, Adachi J, et al. Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosomes Cancer 1996;17:71-7.
27. Kwong FM, Wong PS, Lung ML. Genetic alterations detected on chromosomes 13 and 14 in Chinese non-small cell lung carcinomas. Cancer Lett 2003;192:189-98.
28. Tamura K, Zhang X, Murakami Y, et al. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer 1997;74:45-9.
29. Toyooka S, Toyooka KO, Harada K, et al. Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 2002;62:3382-6.
30. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-15.
31. Mareel M, Bracke M, Van Roy F. Cancer metastasis: negative regulation by an invasion-suppressor complex. Cancer Detect Prev 1995;19:451-64.
32. Braungart E, Schumacher C, Hartmann E, et al. Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer. J Pathol 1999;187:530-4.
33. Waha A, Guntner S, Huang TH, et al. Epigenetic silencing of the protocadherin family member PCDH-γ-A11 in astrocytomas. Neoplasia 2005;7:193-9.
34. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
35. Ying J, Li H, Seng TJ, et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006;25:1070-80. doi:10.1038/sj.onc.1209154.
36. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat 1993;24:175-84.
37. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes up-regulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-9.
38. INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001;61:3419-24.
39. Belinsky SA, Palmisano WA, Gilliland FD, et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 2002;62:2370-7.
40. Frank M, Kemler R. Protocadherins. Curr Opin Cell Biol 2002;14:557-62.
41. Suzuki ST. Recent progress in protocadherin research. Exp Cell Res 2000;261:13-8.